Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2008-12-12

Clinical Trial Update: Leucine Supplementation in Elderly Men [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial update evaluating leucine supplementation in elderly men for sarcopenia and muscle atrophy. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Leucine (Leucine)

Snippet

Sponsor: Maastricht University Medical Center | Conditions: Sarcopenia, Atrophy | Phase 1, Phase 2 | Status: COMPLETED